// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored tec
The scale and speed of the global vaccine research and development effort in response to COVID-19
Innovations in biotherapeutic medicines are advancing at an unprecedented pace and offer great pr